Medicare Enrolled
Dr. Talat Almukhtar, MD, MPH
Hematology & Oncology · Brandon, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Almukhtar from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Almukhtar?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Almukhtar
Dr. Talat Almukhtar is a hematology & oncology specialist in Brandon, FL, with 11 years of NPI registration. Based on federal Medicare data, Dr. Almukhtar performed 121 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Almukhtar received a total of $32,668 from 75 pharmaceutical and/or device companies across 548 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Almukhtar is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 11 years of NPI registration
▲ 121 Medicare services
$32,668 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 135263 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗121
Medicare services
Bottom 7% in FL for hematology & oncology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
Not available
Unique patients (not deduplicated)
$58
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
42 | $86 | $270 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
41 | $8 | $15 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
24 | $54 | $192 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
14 | $125 | $346 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$32,668
Total received (2018-2024)
Avg $4,667/year across 7 years
Top 19% in FL for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
75
Companies
548
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$19,022
2023
$3,915
2022
$8,218
2021
$920
2020
$325
2019
$125
2018
$144
Payments by company (2024)
Pharmacosmos Therapeutics Inc.
$14,933
AstraZeneca Pharmaceuticals LP
$502
PFIZER INC.
$477
Novartis Pharmaceuticals Corporation
$415
Lilly USA, LLC
$230
Eisai Inc.
$223
Celgene Corporation
$220
Regeneron Healthcare Solutions, Inc.
$200
Daiichi Sankyo Inc.
$185
GlaxoSmithKline, LLC.
$140
Tempus AI, Inc
$131
Coherus Biosciences Inc.
$125
BeiGene USA, Inc.
$112
Gilead Sciences, Inc.
$111
PharmaEssentia USA Corporation
$82
Exelixis Inc.
$77
ARRAY BIOPHARMA INC
$74
Fennec Pharmaceuticals, Inc.
$59
JAZZ PHARMACEUTICALS INC.
$51
Janssen Biotech, Inc.
$50
Incyte Corporation
$49
Alexion Pharmaceuticals, Inc.
$49
Alnylam Pharmaceuticals Inc.
$49
Kyowa Kirin, Inc.
$42
Boehringer Ingelheim Pharmaceuticals, Inc.
$41
ACCORD HEALTHCARE, INC.
$38
SOBI, INC
$34
ABBVIE INC.
$34
Takeda Pharmaceuticals U.S.A., Inc.
$32
EMD Serono, Inc.
$32
Kite Pharma, Inc.
$31
Merck Sharp & Dohme LLC
$26
Legend Biotech USA Inc.
$25
Azurity Pharmaceuticals, Inc.
$25
Telix Pharmaceuticals
$23
Astellas Pharma US Inc
$17
Agios Pharmaceuticals, Inc.
$17
Aveo Pharmaceuticals, Inc.
$16
PUMA BIOTECHNOLOGY, INC.
$16
Emmaus Medical, Inc.
$15
MorphoSys, US Inc.
$14
Top 3 companies account for 83.7% of 2024 payments
All-time payments by company (2018-2024) ›
Pharmacosmos Therapeutics Inc.
$19,917
AstraZeneca Pharmaceuticals LP
$1,242
PFIZER INC.
$970
Novartis Pharmaceuticals Corporation
$896
Lilly USA, LLC
$741
Celgene Corporation
$738
Seagen Inc.
$629
Daiichi Sankyo Inc.
$563
Eisai Inc.
$546
Incyte Corporation
$393
Regeneron Healthcare Solutions, Inc.
$361
BeiGene USA, Inc.
$330
Gilead Sciences, Inc.
$304
E.R. Squibb & Sons, L.L.C.
$302
GlaxoSmithKline, LLC.
$297
Exelixis Inc.
$278
Astellas Pharma US Inc
$247
Pharmacyclics LLC, An AbbVie Company
$234
Merck Sharp & Dohme LLC
$226
EISAI INC.
$205
JAZZ PHARMACEUTICALS INC.
$200
GENZYME CORPORATION
$147
Boehringer Ingelheim Pharmaceuticals, Inc.
$147
Tempus AI, Inc
$131
Janssen Biotech, Inc.
$129
Coherus Biosciences Inc.
$125
Amgen Inc.
$118
PUMA BIOTECHNOLOGY, INC.
$103
MorphoSys, US Inc.
$97
ARRAY BIOPHARMA INC
$96
SERVIER PHARMACEUTICALS LLC
$91
Deciphera Pharmaceuticals Inc.
$88
Takeda Pharmaceuticals U.S.A., Inc.
$86
PharmaEssentia USA Corporation
$82
Genentech USA, Inc.
$80
Alexion Pharmaceuticals, Inc.
$80
Stemline Therapeutics Inc.
$74
SOBI, INC
$73
Sobi, Inc
$67
Myovant Sciences Inc.
$62
ACCORD HEALTHCARE, INC.
$62
AVEO Pharmaceuticals, Inc.
$60
Fennec Pharmaceuticals, Inc.
$59
EMD Serono, Inc.
$57
ADC Therapeutics America, Inc.
$55
Kite Pharma, Inc.
$51
G1 Therapeutics, Inc.
$50
Alnylam Pharmaceuticals Inc.
$49
GE HealthCare
$47
Kyowa Kirin, Inc.
$42
Telix Pharmaceuticals
$41
Karyopharm Therapeutics Inc.
$38
Organon LLC
$38
CTI BioPharma Corp.
$37
TG Therapeutics, Inc.
$34
Global Blood Therapeutics, Inc.
$34
Blueprint Medicines Corporation
$34
ABBVIE INC.
$34
Agios Pharmaceuticals, Inc.
$34
Aveo Pharmaceuticals, Inc.
$34
Acrotech Biopharma LLC
$31
Foundation Medicine, Inc.
$29
Legend Biotech USA Inc.
$25
Azurity Pharmaceuticals, Inc.
$25
Sumitomo Pharma America, Inc.
$21
Dendreon Pharmaceuticals LLC
$20
SANOFI-AVENTIS U.S. LLC
$18
Verity Pharmaceuticals Inc.
$18
Heron Therapeutics, Inc.
$17
Taiho Oncology, Inc.
$17
Emmaus Medical, Inc.
$15
Sun Pharmaceutical Industries Inc.
$15
Dova Pharmaceuticals
$14
Janssen Pharmaceuticals, Inc
$13
Rigel Pharmaceuticals, Inc.
$5
Top 3 companies account for 67.7% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · ALUNBRIG · AYVAKIT · BELEODAQ · BESREMI · BLENREP · BOSULIF · BRUKINSA · CABOMETYX · CALQUENCE · CAMCEVI · COSELA · CYRAMZA · Cabometyx · Cinvanti · DARZALEX · DOPTELET · Doptelet · ELREXFIO · ENHERTU · ERLEADA · Endari · Enhertu · FOTIVDA · Fabhalta · GAZYVA · GILOTRIF · HEMADY · IBRANCE · ILLUCCIX · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · JAKAFI · JAYPIRCA · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LOQTORZI · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · MONJUVI · MONOFERRIC · Monoferric · NERLYNX · Nplate · OJJAARA · ONPATTRO · ONTRUZANT · ONUREG · OPDIVO · ORGOVYX · OXBRYTA · Orserdu · PADCEV · PIQRAY · PLUVICTO · PROMACTA · PROVENGE · PYRUKYND · Pedmark · Pomalyst · Poteligeo · QINLOCK · REBLOZYL · RETEVMO · RYBREVANT · Revlimid · Rezlidhia · SARCLISA · SCEMBLIX · SHINGRIX · TAGRISSO · TASIGNA · TEVIMBRA · TIBSOVO · TIVDAK · TUKYSA · Tibsovo · Trelstar · Trodelvy · UKONIQ · ULTOMIRIS · Ultomiris · VERZENIO · VIVIMUSTA · VONJO · Venclexta · Vonjo · XARELTO · XOSPATA · XPOVIO · XT CDX · XTANDI · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
95
County median income
$75,011
Nearest hospital to ZIP centroid (approximate)
HCA FLORIDA BRANDON HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Almukhtar is a clinical cardiology specialist, with moderate Medicare volume.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Almukhtar experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Almukhtar performed 42 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Almukhtar receive payments from pharmaceutical companies?
Yes. Dr. Almukhtar received a total of $32,668 from 75 companies across 548 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Almukhtar's costs compare to other hematology & oncology specialists in Brandon?
Dr. Almukhtar's average Medicare payment per service is $58. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Almukhtar) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Brandon
Browse hematology & oncology specialists in Brandon ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in FL
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in FL
Which FL hematology & oncology specialists receive the most from drug and device companies.
By company
Pharmacosmos Therapeutics Inc. Payments to Doctors
See all physicians who received payments from Pharmacosmos Therapeutics Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology